Expertise in
5
conditions

Noam Benyamini

8, Ha'Aliya Street, 
Haifa, HA, IL 
Expertise in
5
conditions
8, Ha'Aliya Street, 
Haifa, HA, IL 

Overview

Noam Benyamini practices practicing medicine in Haifa, Israel.

Mr. Benyamini is highly rated in 5 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Chronic Myelogenous Leukemia (CML), Non-Hodgkin Lymphoma, Multiple Myeloma, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

8, Ha'Aliya Street, Haifa, HA 31096, Israel
Other Locations
6 Weizmann Street, Tel Aviv, TA 64239, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drugs: Selinexor, Bortezomib, Dexamethasone
Study Phase: Phase 3
The Effect of Active Adherence-Encouraging Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - A Prospective Observational Multicenter Study (TAKE-IT)
The Effect of Active Adherence-Encouraging Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - A Prospective Observational Multicenter Study (TAKE-IT)
Enrollment Status: Completed
Publish Date: June 07, 2017
Intervention Type: Behavioral
Study Phase: Not Applicable
View 1 Less Clinical Trial

42 Total Publications

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.
Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.
Journal: British journal of haematology
Published: March 31, 2026

Frequently Asked Questions about Noam Benyamini

Is Noam Benyamini a top-rated expert for B-Cell Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Noam Benyamini is classified as an Advanced expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Noam Benyamini participate in research or clinical trials?

Yes. Noam Benyamini has published 42 articles and abstracts on conditions like B-Cell Lymphoma. You can view a list of Noam Benyamini's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Benyamini's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile